Fundemo invests in Olix
Funding Provisional 95% confidence first seen
Fundemo invested in Olix, a UK-based AI chip startup founded by James Dacombe, as part of a $312 million funding round that valued the company at $3.3 billion. The round also included investors such as Arm and Netflix cofounder Reed Hastings, tripling Olix's valuation from $1 billion in February. The company plans to deliver its first optical digital processors for AI inference to customers in 2025, positioning itself to compete with Nvidia in the AI infrastructure market.
The deal
Olix $312 million Late stage · announced 3 Aug 2026
Investors Fundemo Arm Reed Hastings
Deal terms as reported in the coverage below.
Decision brief
- What changed
- UK AI chip startup Olix, founded by James Dacombe, raised $312m at a $3.3bn valuation (up from $1bn in February) from investors including Fundemo, Arm, and Reed Hastings; the company plans to tape out chips this year with first products reaching customers in 2025.
- Why it matters
- A tripling of valuation in months signals strong investor appetite for alternatives to Nvidia in AI chip supply, which matters for enterprises planning compute procurement and for competitors watching supply-chain diversification. If Olix delivers cheaper, faster chips by sidestepping components in short supply, it could shift sourcing options and pricing dynamics in AI infrastructure over the next 1-2 years, though this remains speculative until products ship.
- Evidence
- Single-source report from Sifted covering the funding round, valuation jump, and investor list; no independent corroboration provided in the given coverage.
- What remains uncertain
- It's unverified whether Olix's chips will actually match or beat Nvidia's performance/cost claims once taped out, and the 2025 customer timeline is a company projection not yet confirmed by third parties. The strategic rationale for Fundemo's specific investment and its stake size are not detailed in this single-source account.
- Monitor next
- Watch for confirmation of the chip tape-out later this year and any independent technical or customer validation ahead of the 2025 product rollout.
Analytical support, not advice — assumptions and open questions stated above.